MESA LABORATORIES INC CO (MLAB)
2025-06-30 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 59,543 | 62,840 | 57,833 | 58,170 |
| Cost of revenues | 22,604 | 23,086 | 22,378 | 20,921 |
| Gross profit | 36,939 | 39,754 | 35,455 | 37,249 |
| Selling | 10,933 | 10,450 | 9,849 | 10,116 |
| Research and development | 4,984 | 5,053 | 4,634 | 4,735 |
| General and administrative | 17,958 | 18,472 | 17,464 | 16,818 |
| Total operating expense | 33,875 | 33,975 | 31,947 | 31,669 |
| Operating income | 3,064 | 5,779 | 3,508 | 5,580 |
| Other (income) expense, net | 6,146 | -5,154 | 3,322 | -2,030 |
| Interest expense and amortization of debt issuance costs | 2,198 | 2,842 | 3,018 | 2,842 |
| Gain on extinguishment of convertible notes | - | - | - | 3,197 |
| Total non-operating (income) expense, net | 3,948 | -7,996 | 304 | -1,675 |
| Earnings before income taxes | 7,012 | -2,217 | 3,812 | 3,905 |
| Income tax expense | 2,270 | -541 | 384 | 517 |
| Net income | 4,742 | -1,676 | 3,428 | 3,388 |
| Basic (in dollars per share) | 0.87 | -0.31 | 0.63 | 0.63 |
| Diluted (in dollars per share) | 0.85 | -0.31 | 0.63 | 0.62 |
| Diluted (in shares) | 5,553,000 | 5,429,000 | 5,471,000 | 5,424,000 |
| Weighted average outstanding shares of common stock (in shares) | 5,465,000 | 5,429,000 | 5,413,000 | 5,397,000 |